5MXX | Splicing | date | Jan 25, 2017 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Human Sr Protein Kinase 1 (Srpk1) In Co Compound 1 | ||||||||||||||
authors | C.Tallant, C.Redondo, J.Batson, H.D.Toop, R.Babaebi-Jadidib, P.Sa J.M.Elkins, J.A.Newman, N.Burgess-Brown, F.Von Delft, C.H.Arrow A.M.Edwards, C.Bountra, D.O.Bates, J.C.Morris, S.Knapp, Structur Genomics Consortium (Sgc) | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Srpk1 Chain: A Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_vector_type: Plasmid Expression_system_plasmid: Pnic28-Bsa4 | ||||||||||||||
symmetry | Space Group: P 43 21 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.75 Å | ||||||||||||
ligand | CA, EDO, TRS, W4A | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease., Batson J, Toop HD, Redondo C, Babaei-Jadidi R, Chaikuad A, Wearmouth SF, Gibbons B, Allen C, Tallant C, Zhang J, Du C, Hancox JC, Hawtrey T, Da Rocha J, Griffith R, Knapp S, Bates DO, Morris JC, ACS Chem Biol. 2017 Mar 17;12(3):825-832. doi: 10.1021/acschembio.6b01048. Epub, 2017 Feb 6. PMID:28135068 |
Data retrieval |
View 5MXX in 3D |
Visual 3D analysis of 5MXX |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5MXX |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |